Furthermore, adenoviral-based reintroduction of P16INK4a or P14ARF showed reversal of mesothelioma growth by decreasing hyper-phosphorylation of RB, increasing p53 levels, and ultimately resulted in cell cycle arrest [43]. The gene discussed is CDKN2A; the disease is mesothelioma.